GRTS Research and Charts

GRTS - Gritstone Bio Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-12 (Delayed quote data 2024-10-21)

Last 0.03	Change ⇓ -0.02 (0.00%)	Volume 57,927,407
	Open 0.04	High 0.04	Low 0.03

8EMA (Daily) 0.08	40EMA (Daily) 0.32	50EMA (Daily) 0.37	STO (Daily) 0.984	MACD Hist (Daily) -0.021
8EMA (Weekly) 0.251	40EMA (Weekly) 0.89	50EMA (Weekly) 1.06	STO (Weekly) 11.221	MACD Hist (Weekly) -0.039


Company Profile
Gritstone Bio Inc is a United States-based biotechnology company. It is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, BiSAb, among others.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.